292 related articles for article (PubMed ID: 30595291)
21. The periprocedural myocardial damage prevention during elective percutaneous coronary intervention as a result of pharmacological preconditioning with an oral form of nicorandil in patients with stable coronary artery disease. Pilot study.
Gostishchev RV; Soboleva GN; Samko AN; Rogoza AN; Minasyan AA
Ter Arkh; 2018 Sep; 90(9):53-59. PubMed ID: 30701736
[TBL] [Abstract][Full Text] [Related]
22. Effects of trimetazidine in patients with acute myocardial infarction: data from the Korean Acute Myocardial Infarction Registry.
Kim JS; Kim CH; Chun KJ; Kim JH; Park YH; Kim J; Choi JH; Lee SH; Kim EJ; Yu DG; Ahn EY; Jeong MH
Clin Res Cardiol; 2013 Dec; 102(12):915-22. PubMed ID: 23982468
[TBL] [Abstract][Full Text] [Related]
23. Protective effect of metformin on myocardial injury in metabolic syndrome patients following percutaneous coronary intervention.
Li J; Xu JP; Zhao XZ; Sun XJ; Xu ZW; Song SJ
Cardiology; 2014; 127(2):133-9. PubMed ID: 24335026
[TBL] [Abstract][Full Text] [Related]
24. Trimetazidine improves recovery during reperfusion in isolated rat hearts after prolonged ischemia.
Ikizler M; Dernek S; Sevin B; Kural T
Anadolu Kardiyol Derg; 2003 Dec; 3(4):303-8. PubMed ID: 14675878
[TBL] [Abstract][Full Text] [Related]
25. High-sensitivity cardiac troponin T is more helpful in detecting peri-operative myocardial injury and apoptosis during coronary artery bypass graft surgery.
Kocak EF; Kocak C; Aksoy A; Isiklar OO; Akcilar R; Ozdomanic IF; Unsal C; Celenk M; Altuntas I
Cardiovasc J Afr; 2015; 26(6):234-41. PubMed ID: 26212819
[TBL] [Abstract][Full Text] [Related]
26. Biomarker release after percutaneous coronary intervention in patients without established myocardial infarction as assessed by cardiac magnetic resonance with late gadolinium enhancement.
Vieira de Melo RM; Hueb W; Nomura CH; Ribeiro da Silva EE; Villa AV; Oikawa FTC; da Costa LMA; Rezende PC; Garzillo CL; Lima EG; Franchini Ramires JA; Kalil Filho R
Catheter Cardiovasc Interv; 2017 Jul; 90(1):87-93. PubMed ID: 28573785
[TBL] [Abstract][Full Text] [Related]
27. Biochemical detection of minor myocardial injury after elective, uncomplicated, successful percutaneous coronary intervention in patients with stable angina: clinical outcome.
Saadeddin SM; Habbab MA; Sobki SH; Ferns GA
Ann Clin Biochem; 2002 Jul; 39(Pt 4):392-7. PubMed ID: 12117443
[TBL] [Abstract][Full Text] [Related]
28. Remote ischemic post-conditioning of the lower limb during primary percutaneous coronary intervention safely reduces enzymatic infarct size in anterior myocardial infarction: a randomized controlled trial.
Crimi G; Pica S; Raineri C; Bramucci E; De Ferrari GM; Klersy C; Ferlini M; Marinoni B; Repetto A; Romeo M; Rosti V; Massa M; Raisaro A; Leonardi S; Rubartelli P; Oltrona Visconti L; Ferrario M
JACC Cardiovasc Interv; 2013 Oct; 6(10):1055-63. PubMed ID: 24156966
[TBL] [Abstract][Full Text] [Related]
29. Prevention of peri-procedural myocardial injury using a single high loading dose of rosuvastatin.
Cay S; Cagirci G; Sen N; Balbay Y; Durmaz T; Aydogdu S
Cardiovasc Drugs Ther; 2010 Feb; 24(1):41-7. PubMed ID: 20217203
[TBL] [Abstract][Full Text] [Related]
30. [Effects of pretreatment with recombinant human B-type natriuretic peptide on infarct size in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention].
Li S; Fu X; Dai Y; Liu C; Wang Y; Li W; Wu W; Gu X; Hao G; Fan W; Miao Q; Jiang Y
Zhonghua Xin Xue Guan Bing Za Zhi; 2015 Nov; 43(11):954-9. PubMed ID: 26888806
[TBL] [Abstract][Full Text] [Related]
31. Prognostic value of cardiac troponin I elevation after percutaneous coronary intervention in patients with chronic renal insufficiency: a 12-month outcome analysis.
Gruberg L; Fuchs S; Waksman R; Pichard AD; Kent KM; Laird JR; Wu H; Elsayyad S; Allen CM; Satler LF
Catheter Cardiovasc Interv; 2002 Feb; 55(2):174-9. PubMed ID: 11835642
[TBL] [Abstract][Full Text] [Related]
32. Glycogen phosphorylase isoenzyme BB, creatine kinase isoenzyme MB and troponin I for monitoring patients with percutaneous coronary intervention - a pilot study.
Skitek M; Kranjec I; Jerin A
Med Glas (Zenica); 2014 Feb; 11(1):13-8. PubMed ID: 24496335
[TBL] [Abstract][Full Text] [Related]
33. Impact of trimetazidine on incidence of myocardial injury and contrast-induced nephropathy in diabetic patients with renal dysfunction undergoing elective percutaneous coronary intervention.
Shehata M
Am J Cardiol; 2014 Aug; 114(3):389-94. PubMed ID: 24927970
[TBL] [Abstract][Full Text] [Related]
34. Cardioprotective Effects of Nicorandil on Coronary Heart Disease Patients Undergoing Elective Percutaneous Coronary Intervention.
Pang Z; Zhao W; Yao Z
Med Sci Monit; 2017 Jun; 23():2924-2930. PubMed ID: 28617765
[TBL] [Abstract][Full Text] [Related]
35. Effect of short-term high-dose atorvastatin on systemic inflammatory response and myocardial ischemic injury in patients with unstable angina pectoris undergoing percutaneous coronary intervention.
Sun F; Yin Z; Shi Q; Zhao B; Wang S
Chin Med J (Engl); 2014; 127(21):3732-7. PubMed ID: 25382328
[TBL] [Abstract][Full Text] [Related]
36. The effect of exogenous creatine phosphate on myocardial injury after percutaneous coronary intervention.
Ke-Wu D; Xu-Bo S; Ying-Xin Z; Shi-Wei Y; Yu-Jie Z; Dong-Mei S; Yu-Yang L; De-An J; Zhe F; Zhi-Ming Z; Hai-Long G; Zhen-Xian Y; Chang-Sheng M
Angiology; 2015 Feb; 66(2):163-8. PubMed ID: 24368725
[TBL] [Abstract][Full Text] [Related]
37. Percutaneous coronary intervention for poor coronary microcirculation reperfusion of patients with stable angina pectoris.
Li JS; Zhao XJ; Ma BX; Wang Z
J Biol Regul Homeost Agents; 2016; 30(3):733-741. PubMed ID: 27655490
[TBL] [Abstract][Full Text] [Related]
38. The protective effect of trimetazidine on myocardial ischemia/reperfusion injury through activating AMPK and ERK signaling pathway.
Liu Z; Chen JM; Huang H; Kuznicki M; Zheng S; Sun W; Quan N; Wang L; Yang H; Guo HM; Li J; Zhuang J; Zhu P
Metabolism; 2016 Mar; 65(3):122-30. PubMed ID: 26892523
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and safety of trimetazidine after percutaneous coronary intervention (ATPCI): a randomised, double-blind, placebo-controlled trial.
Ferrari R; Ford I; Fox K; Challeton JP; Correges A; Tendera M; Widimský P; Danchin N;
Lancet; 2020 Sep; 396(10254):830-838. PubMed ID: 32877651
[TBL] [Abstract][Full Text] [Related]
40. Cardioprotective effects of intracoronary adenosine in diabetic patients undergoing elective percutaneous coronary intervention.
Shehata M
Minerva Cardioangiol; 2014 Dec; 62(6):461-71. PubMed ID: 24699551
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
